2024-2030 China Biopharmaceutical Outsourcing Industry Market Operation Situation Future Trend Research and Judgment Report

2024-2030 China Biopharmaceutical Outsourcing Industry Market Operation Situation and Future Trend Research and Judgment Report

Report No.: 1758751

Free catalog download: http://www.cninfo360.com/yjbg/yyhy/ylqx/20240117/1758751.html

　　The current market status of China's biopharmaceutical outsourcing industry

　　As an emerging industry, China's biopharmaceutical outsourcing industry has achieved rapid development in the past few years. According to the China Business and Economic Information Center, the scale of China's biomedical outsourcing market reached 5.82 billion yuan in 2015, further increased to 6.73 billion yuan in 2016, 8.11 billion yuan in 2017, and reached 10.22 billion yuan in 2019, a year-on-year increase of 11.1%. By 2020, the scale of China's biomedical outsourcing market will exceed 11 billion yuan, with a rapid growth trend.

　　In recent years, China's biopharmaceutical outsourcing industry has developed rapidly, mainly in the following aspects:

　　With the continuous improvement of technology, all kinds of biomedical outsourcing services have been well developed. Now, some large outsourcing companies are starting to provide more complex services to their customers, such as clinical research, drug discovery and development, commercial marketing, etc. With the increase of national investment in this field, the scope of services of outsourcing enterprises will be further expanded.

　　The state's support for the biomedical outsourcing industry has also promoted the development of the industry, such as in terms of fiscal policy, the state supports enterprises to develop biomedical outsourcing business, such as tax exemptions. The state has also launched a development plan for the outsourcing industry to provide policy support and investment incentives for enterprises.

　　Thirdly, the efficient management and technological innovation of outsourcing enterprises have also promoted the development of the industry. Outsourcing enterprises actively take effective management measures to improve their own business level, and in terms of technological innovation, they are also constantly developing new products and services.

　　Competitive landscape

　　The competition in China's biopharmaceutical outsourcing industry is fierce, mainly in the following aspects:

　　The outsourcing industry faces fierce competition for resources. Due to the strong support of the state for the industry, major outsourcing companies are competing for limited resources, such as high-quality talents, funds, etc., and this competition has caused certain pressure on the development of enterprises.

　　The technology competition between enterprises is also very fierce. Due to the continuous advancement of technological innovation, outsourcing companies are striving to improve their technical level, constantly develop new products and services, and improve service quality, so as to gain more customers.

　　Price competition is also an important aspect of fierce competition in the outsourcing industry. In order to attract more customers, major outsourcing companies have begun to offer competitive prices in order to win more market share.

　　The competition in China's biopharmaceutical outsourcing industry is fierce, and outsourcing companies need to improve their technical level, increase R&D investment, provide better services, seize market opportunities, and achieve sustainable development of enterprises.

The "2024-2030 China Biopharmaceutical Outsourcing Industry Market Operation Situation and Future Trend Research and Judgment Report" released by Boyan Consulting consists of eight chapters. Firstly, the market development environment of the biomedical outsourcing industry and the overall operation situation of the biomedical outsourcing industry are introduced, and then the current situation of the market operation of the biomedical outsourcing industry is analyzed, and then the competition pattern of the biomedical outsourcing market is introduced. Subsequently, the report analyzes the business status of key enterprises in biomedical outsourcing, and finally analyzes the development trend and investment forecast of biomedical outsourcing industry. If you want to have a systematic understanding of the biomedical outsourcing industry or want to invest in the biomedical outsourcing industry, this report is an indispensable and important tool for you.

The data of this research report mainly use national statistical data, General Administration of Customs, questionnaire survey data, and data collected by the Ministry of Commerce. Among them, the macroeconomic data mainly comes from the National Bureau of Statistics, some industry statistics mainly come from the National Bureau of Statistics and market research data, the enterprise data mainly comes from the National Bureau of Statistics large-scale enterprise statistical database and stock exchanges, etc., and the price data mainly comes from various market monitoring databases.

Table of contents of the text

Chapter 1 Overview of the Biomedical Outsourcing Industry and Data Sources

1.1 Definition of biomedical industry

1.1.1 Definition of biomedicine

1.1.2 Classification of biomedicine

1.1.3 Classification and Coding of Biomedical Industries in the National Economic Industry Classification and Code

1.2 Definition of biomedical outsourcing industry

1.2.1 Definition of biomedical outsourcing

1.2.2 Identification of similar concepts of biomedical outsourcing

1.2.3 Classification of biomedical outsourcing

1.3 Explanation of professional terms for biomedical outsourcing

1.4 Description of the scoping of the study in this report

1.5 Description of data sources and statistical standards in this report

1.5.1 Authoritative data sources for this report

1.5.2 Description of the research methodology and statistical standards of this report

2. Macro Environment Analysis of China's Biopharma Outsourcing Industry (PEST)

2.1 Analysis of the policy environment of China's biopharmaceutical outsourcing industry

2.1.1 Introduction to the regulatory system and institutions of China's biopharmaceutical outsourcing industry

(1) The competent authority of China's biomedical outsourcing industry

(2) Self-regulatory organization of China's biomedical outsourcing industry

2.1.2 The status quo of the construction of China's biomedical outsourcing industry standard system

(1) Summary of the current standards for biopharmaceutical outsourcing in China

(2) Key standards for biopharmaceutical outsourcing in China

2.1.3 Summary of policies and plans related to the development of China's biomedical outsourcing industry

(1) Summary of policies related to the development of China's biomedical outsourcing industry

(2) Summary of relevant plans for the development of China's biomedical outsourcing industry

2.1.4 Analysis of the impact of the 14th Five-Year Plan on the biomedical outsourcing industry

2.1.5 Summary of the impact of the policy environment on the development of the biomedical outsourcing industry

2.2 Analysis of the economic environment of China's biopharmaceutical outsourcing industry

2.2.1 Current status of China's macroeconomic development

2.2.2 Macroeconomic outlook for China

2.2.3 Analysis of the development of China's biomedical outsourcing industry and macroeconomic correlation

2.3 Analysis of the social environment of China's biomedical outsourcing industry

2.3.1 Analysis of the social environment of China's biopharmaceutical outsourcing industry

2.3.2 Summary of the impact of social environment on the development of the biomedical outsourcing industry

2.4 Analysis of the Technology Environment of China's Biomedical Outsourcing Industry

2.4.1 Diagram of technology/process/flow of China's biopharmaceutical outsourcing industry

2.4.2 Analysis of key/emerging technologies in China's biopharmaceutical outsourcing industry

(1) Analysis of key technologies in China's biopharmaceutical outsourcing industry

(2) Integration and application of emerging technologies of biopharmaceutical outsourcing in China

2.4.3 R&D investment in China's biopharmaceutical outsourcing industry

2.4.4 Scientific research and innovation achievements in China's biomedical outsourcing industry

(1) Patent application for China's biomedical outsourcing industry

(2) Patent disclosure in China's biopharmaceutical outsourcing industry

(3) Popular applicants in China's biopharmaceutical outsourcing industry

(4) Popular technologies in China's biomedical outsourcing industry

2.4.5 Summary of the impact of the technical environment on the development of the biomedical outsourcing industry

Chapter 3 Research on the Development Status of the Global Biopharmaceutical Outsourcing Industry and Market Trend Insights

3.1 Introduction to the development process of the global biomedical outsourcing industry

3.2 Macro environment background of the global biomedical outsourcing industry

3.2.1 Overview of the economic environment of the global biopharmaceutical outsourcing industry

3.2.2 Impact analysis on the global biopharmaceutical outsourcing industry

3.3 Analysis of the development status and market size of the global biopharmaceutical outsourcing industry

3.4 Regional development pattern and key regional market research of the global biopharmaceutical outsourcing industry

3.4.1 Regional development pattern of the global biopharmaceutical outsourcing industry

3.4.2 Analysis of key regions of the global biopharmaceutical outsourcing industry

3.5 Market competition pattern and case studies of key enterprises in the global biopharmaceutical outsourcing industry

3.5.1 Global Biomedical Outsourcing Industry Market Competition Pattern

3.5.2 Mergers and acquisitions of global biomedical outsourcing enterprises

3.5.3 Cases of key enterprises in the global biomedical outsourcing industry

3.6 Prediction of the development trend and market prospect of the global biomedical outsourcing industry

3.6.1 Prediction of the development trend of the global biopharmaceutical outsourcing industry

3.6.2 Global Biopharmaceutical Outsourcing Industry Market Prospect Forecast

3.7 Lessons from the development experience of the global biopharmaceutical outsourcing industry

Chapter 4 Analysis of the Market Supply and Demand and Development Pain Points of China's Biopharmaceutical Outsourcing Industry

4.1 Development history of China's biomedical outsourcing industry

4.2 Types of market players and entry methods in China's biopharmaceutical outsourcing industry

4.3 The size and characteristics of market players in China's biopharmaceutical outsourcing industry

4.3.1 The size of the market in China's biopharmaceutical outsourcing industry

4.3.2 Characteristics of registered enterprises in China's biomedical outsourcing industry

(1) Distribution of registered capital of registered enterprises in China's biomedical outsourcing industry

(2) Distribution of registered enterprises in China's biopharmaceutical outsourcing industry

4.4 Market supply of China's biopharmaceutical outsourcing industry

4.4.1 Analysis of the market supply capacity of China's biopharmaceutical outsourcing industry

4.4.2 Analysis of the market supply level of China's biopharmaceutical outsourcing industry

4.5 Bidding market for China's biomedical outsourcing industry

4.5.1 Summary of bidding information in China's biopharmaceutical outsourcing industry

4.5.2 Bidding information of China's biopharmaceutical outsourcing industry

4.6 Market demand in China's biopharmaceutical outsourcing industry

4.6.1 Analysis of demand characteristics of China's biopharmaceutical outsourcing industry

4.6.2 Analysis of the current demand of China's biopharmaceutical outsourcing industry

4.7 Supply and demand balance and market trend of China's biopharmaceutical outsourcing industry

4.7.1 Analysis of the balance between supply and demand in China's biopharmaceutical outsourcing industry

4.7.2 Market trend of China's biopharmaceutical outsourcing industry

4.8 Estimation of the market size of China's biopharmaceutical outsourcing industry

4.9 Analysis of market pain points in China's biopharmaceutical outsourcing industry

Chapter 5 Market Competition and M&A Analysis of China's Biopharmaceutical Outsourcing Industry

5.1 Market competition layout of China's biopharmaceutical outsourcing industry

5.1.1 Entry process of competitors in China's biopharmaceutical outsourcing industry

5.1.2 Heat map of the regional distribution of competitors in China's biopharmaceutical outsourcing industry

5.1.3 The strategic layout of the development strategy of competitors in China's biopharmaceutical outsourcing industry

5.2 Market competition pattern of China's biopharmaceutical outsourcing industry

5.2.1 Strategic clusters of enterprises in China's biopharmaceutical outsourcing industry

5.2.2 Analysis of the competitive landscape of enterprises in China's biopharmaceutical outsourcing industry

5.3 Analysis of market concentration in China's biopharmaceutical outsourcing industry

5.4 Porter's Five Forces Model Analysis of China's Biopharmaceutical Outsourcing Industry

5.4.1 Bargaining power of suppliers in China's biopharmaceutical outsourcing industry

5.4.2 Bargaining power of consumers in China's biopharmaceutical outsourcing industry

5.4.3 Threat of new entrants in China's biopharmaceutical outsourcing industry

5.4.4 Threat of substitutes in China's biopharmaceutical outsourcing industry

5.4.5 Competition among existing enterprises in China's biomedical outsourcing industry

5.4.6 Summary of the competitive status of China's biopharmaceutical outsourcing industry

5.5 Investment, financing, mergers and acquisitions in China's biopharmaceutical outsourcing industry

5.5.1 Investment and financing development of China's biopharmaceutical outsourcing industry

5.5.2 Mergers and acquisitions in China's biopharmaceutical outsourcing industry

Chapter 6 Research on the Structure and Layout of China's Biopharmaceutical Outsourcing Industry Chain

6.1 Analysis of the industrial chain map of China's biomedical outsourcing industry

6.2 Analysis of the value attribute (value chain) of China's biomedical outsourcing industry

6.2.1 Cost structure analysis of China's biopharmaceutical outsourcing industry

6.2.2 Value chain analysis of China's biopharmaceutical outsourcing industry

6.3 China Biopharma R&D Outsourcing (CRO) Market Analysis

6.4 China Biopharmaceutical Manufacturing Outsourcing (CMO/CDMO) Market Analysis

6.5 Market analysis of other outsourcing links of biomedicine in China

Chapter 7 Case Study of Key Enterprises in China's Biopharmaceutical Outsourcing Industry

7.1 Sorting out and comparing the layout of key enterprises in China's biomedical outsourcing

7.2 Case study of the layout of key enterprises in China's biomedical outsourcing

7.2.1 Wuxi AppTec New Drug Development Co., Ltd

(1) Company profile